Published in Stud Health Technol Inform on January 01, 1997
Testing the Technology Acceptance Model: HIV case managers' intention to use a continuity of care record with context-specific links. Inform Health Soc Care (2011) 0.86
Perceptions of factors influencing use of an electronic record for case management of persons living with HIV. AIDS Care (2011) 0.79
Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell (1998) 4.41
Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology (2005) 2.69
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology (2007) 2.51
Elevation of serum copper levels in Alzheimer's disease. Neurology (2002) 1.93
Multicenter randomised trial on home-based telemanagement to prevent hospital readmission of patients with chronic heart failure. Int J Cardiol (2008) 1.88
Influence of tetramisole and its optical isomers on the mononuclear phagocytic system. Effect on carbon clearance in mice. J Reticuloendothel Soc (1973) 1.66
Amplifying effect of sumatriptan on noradrenaline venoconstriction in migraine patients. Cephalalgia (1993) 1.41
[On post-traumatic ptosis]. Rev Stomatol Chir Maxillofac (2003) 1.40
Prevalence of hereditary ataxias and spastic paraplegias in Molise, a region of Italy. J Neurol (1992) 1.39
Predictors of mortality in patients with Eisenmenger syndrome and admission to the lung transplantation waiting list. Monaldi Arch Chest Dis (2005) 1.38
[Congenital skin lacunae. Etio-pathogenetic considerations apropos of 2 cases with thoraco-abdominal localization]. Minerva Pediatr (1972) 1.33
Medicines for children licensed by the European Medicines Agency (EMEA): the balance after 10 years. Eur J Clin Pharmacol (2006) 1.29
Genetic data and natural history of Friedreich's disease: a study of 80 Italian patients. J Neurol (1990) 1.26
A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3. Am J Hum Genet (1998) 1.25
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology (1999) 1.25
A contribution to the interpretation of shock and pain in myocardial infarction. Mal Cardiovasc (1967) 1.13
Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products. Eur J Clin Pharmacol (2002) 1.13
Environmental and genetic risk factors in Parkinson's disease: a case-control study in southern Italy. Mov Disord (1996) 1.11
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer. Br J Cancer (2006) 1.10
Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families. Neuromuscul Disord (2000) 1.09
Three-dimensional sonographic diagnosis of ovarian pregnancy. Ultrasound Obstet Gynecol (2005) 1.08
Evidence supporting the presence of Borrelia burgdorferi in Missouri. Am J Trop Med Hyg (1994) 1.08
Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults. Eur Respir J (2007) 1.08
Microbes bind complement inhibitor factor H via a common site. PLoS Pathog (2013) 1.06
d-penicillamine reduces serum oxidative stress in Alzheimer's disease patients. Eur J Clin Invest (2002) 1.04
Interaction and dialogue between the users and the patient record core of hospital information system: looking for a solution. Proc Annu Symp Comput Appl Med Care (1995) 1.04
Assessing users' satisfaction through perception of usefulness and ease of use in the daily interaction with a hospital information system. Proc AMIA Annu Fall Symp (1996) 1.01
Impact of the new european paediatric regulatory framework on ethics committees: overview and perspectives. Acta Paediatr (2011) 1.00
Chemotherapy of a spontaneous mammary carcinoma in mice: relation between in vitro-in vivo activity and blood and tumor concentrations of serveral antitumor drugs. Cancer Chemother Rep (1973) 1.00
Effect of Triton WR 1339 on cancer dissemination and metastases. Eur J Cancer (1969) 0.98
1,2,3-Triazolo[1,5-a][1,4]- and 1,2,3-triazolo[1,5-a]-[1,5]benzodiazepine derivatives: synthesis and benzodiazepine receptor binding. Farmaco (1998) 0.96
Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms. Neurol Sci (2001) 0.96
The relationship between cerebral vascular disease and parkinsonism: The VADO study. Parkinsonism Relat Disord (2012) 0.96
The determinants of performance in master swimmers: a cross-sectional study on the age-related changes in propelling efficiency, hydrodynamic position and energy cost of front crawl. Eur J Appl Physiol (2012) 0.94
Impairement of drug metabolism in tumor-bearing animals. Eur J Cancer (1971) 0.94
Characterization of the immunostimulants levamisole and tetramisole. Eur J Cancer (1975) 0.94
Some structural changes on triazolyl-benzotriazoles and triazolyl-benzimidazolones as potential potassium channel activators. III. Farmaco (2001) 0.93
Do parkinsonian symptoms and levodopa-induced dyskinesias start in the foot? Neurology (1994) 0.91
Visual responses in the dorsal premotor area F2 of the macaque monkey. Exp Brain Res (1999) 0.91
The effects of aging on enzyme activities and metabolite concentrations in skeletal muscle from sedentary male and female subjects. Exp Gerontol (2000) 0.91
[The test of venoconstriction for the measurement of sensitivity to 5-hydroxytryptamine and catecholamines in man]. Boll Soc Ital Biol Sper (1964) 0.90
An antaminic drug, BC 105, in the prophylaxis of migraine. Pharmacological, clinical, and therapeutic experiences. Int Arch Allergy Appl Immunol (1967) 0.90
Successful private-public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines. Eur J Pediatr (2014) 0.90
Motor responses mediated by orthodromic and antidromic activation of the rostral portion of the cat corpus callosum. Exp Brain Res (1986) 0.89
Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone. J Med Chem (1975) 0.89
[A pediatric case of Alveolar Soft Part Sarcoma]. Rev Stomatol Chir Maxillofac (2007) 0.89
Autosomal recessive early onset parkinsonism is linked to three loci: PARK2, PARK6, and PARK7. Neurol Sci (2002) 0.89
Role of galanin receptor 1 in peristaltic activity in the guinea pig ileum. Neuroscience (2004) 0.88
Clinical and imaging characterization of a patient with idiopathic progressive ataxia and palatal tremor. Eur J Neurol (2007) 0.87
The effect of cytotoxic agents on drug metabolism. Eur J Cancer (1970) 0.87
Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: a follow-up of two years. Arch Gerontol Geriatr Suppl (2004) 0.86
Reduction of bone density: an effect of gonadotropin releasing hormone analogue treatment in central precocious puberty. Eur J Pediatr (1993) 0.85
Familial hemiplegic migraine type 2 does not share hypersensitivity to nitric oxide with common types of migraine. Cephalalgia (2008) 0.85
The parkin gene and its phenotype. Italian PD Genetics Study Group, French PD Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Neurol Sci (2001) 0.84
Depression after lung transplantation: causes and treatment. Lung (2007) 0.84
Efficacy and safety of leflunomide or methotrexate plus subcutaneous tumour necrosis factor-alpha blocking agents in rheumatoid arthritis. Int J Immunopathol Pharmacol (2011) 0.83
The economic burden of biological therapy in rheumatoid arthritis in clinical practice: cost-effectiveness analysis of sub-cutaneous anti-TNFalpha treatment in Italian patients. Int J Immunopathol Pharmacol (2010) 0.83
Xanthine oxidase inhibition: effect of an N-alkyl substituent on C-2 of the nucleus of 8-azahypoxanthine. Farmaco (1989) 0.83
Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): The Maugeri Study. Respir Med (2007) 0.82
Selective chemotherapy of cancer metastases with triton WR 1339. Eur J Cancer (1971) 0.82
[Malignant mesothelioma: analysis of a hospital case series]. G Ital Med Lav Ergon (2013) 0.82
Experience of hepatitis A vaccination during an outbreak in a nursery school of Tuscany, Italy. Epidemiol Infect (1998) 0.82
Smoking habits in multiple system atrophy and progressive supranuclear palsy. European Study Group on Atypical Parkinsonisms. Neurology (2000) 0.81
A genetic study of Parkinson's disease. J Neural Transm Suppl (1995) 0.81
PIVKA-II plasma levels as markers of subclinical vitamin K deficiency in term infants. J Matern Fetal Neonatal Med (2012) 0.81
Triton WR 1339 (TWR), an inhibitor of cancer dissemination and metastases. Eur J Cancer (1971) 0.81
Clinical validation of an anxiety and depression screening test for intensive in-hospital rehabilitation. Monaldi Arch Chest Dis (2002) 0.81
Correlation between atopy and hypersensitivity reactions during therapy with three different TNF-alpha blocking agents in rheumatoid arthritis. Clin Exp Rheumatol (2009) 0.80
Studies on specific inhibition of benzodiazepine receptor binding by some C-benzoyl-1,2,3-triazole derivatives. J Pharm Sci (1993) 0.80
Metabolic fate of zoxazolamine in tumor bearing rats. Biochem Pharmacol (1969) 0.80
Second Life virtual world: a heaven for autistic people? Med Hypotheses (2008) 0.80
Prevalence of Parkinson's disease and other types of parkinsonism in the Aeolian Archipelago, Sicily. Parkinsonism Relat Disord (2008) 0.80
Alpha-synuclein promoter haplotypes and dementia in Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet (2008) 0.80
Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms. Neurol Sci (2001) 0.80
Altered muscle energy metabolism in post-absorptive patients with chronic renal failure. Scand J Urol Nephrol (1997) 0.80
Soluble interleukin 2 receptor (sIL2R) in monitoring advanced lung cancer during chemotherapy. Lung Cancer (1999) 0.80
[Anxiety and Depression Short Scale: norms for its use in rehabilitation]. Monaldi Arch Chest Dis (2006) 0.80
Synthesis of 4,6-disubstituted- and 4,5,6-trisubstituted-2-phenyl-pyrimidines and their affinity towards A1 adenosine receptors. Farmaco (1997) 0.80
Rehabilitation of the paralysed or lax lower eyelid using a graft of conchal cartilage. Br J Plast Surg (2002) 0.80
Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study. Parkinsonism Relat Disord (2009) 0.80
[Fracture of the medial wall of the orbit. Apropos of 4 cases]. Rev Stomatol Chir Maxillofac (1995) 0.79
[Caregiver and care: from needs assessment to alliance in the therapeutic path]. G Ital Med Lav Ergon (2007) 0.79
Determinants of Risk Infection During Therapy with Anti TNF-Alpha Blocking Agents in Rheumatoid Arthritis. Open Rheumatol J (2012) 0.79
Change in serotonin and catecholamines vascular reactivity during migraine attack. Res Clin Stud Headache (1970) 0.79
Somatostatin: peripheral venoconstrictive activity and interaction with monoamines in man. Regul Pept (1987) 0.79
A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine. Mov Disord (1995) 0.79
[Evaluation of usability of an e-learning software in healthcare]. G Ital Med Lav Ergon (2009) 0.79
The assessment of path linearity in swimming: a pilot study. Int J Sports Med (2008) 0.79
Pergolide monotherapy in the treatment of early PD: a randomized, controlled study. Pergolide Monotherapy Study Group. Neurology (1999) 0.79